Monday, October 26, 2026 · Daily editionET --:--:--

Stopped early

Overground Walking Program With Robotic Exoskeleton in Long-term Manual Wheelchair Users With Spinal Cord Injury

NCT03989752 · Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal · Updated 8 Sept 2023

What is being tested
Wearable Robotic Exoskeleton for Ambulation
For
Spinal Cord Injuries
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 16 people. The full rules are on the registry page.
Where
Canada
When
Starts or started 14 March 2019, ends 7 Jan 2022. Registered 18 June 2019.
Results
None posted yet.

In the researchers' words

Many individuals with a spinal cord injury (SCI) use a wheelchair as their primary mode of locomotion. The prolonged non-active sitting time associated to this mode of locomotion contributes to development or worsening of numerous adverse health effects affecting musculoskeletal, endocrino-metabolic and cardiorespiratory health. To counter this vicious circle, engaging in a walking program with a wearable robotic exoskeleton (WRE) is a promising physical activity intervention. This study aims to measure the effects of a WRE-assisted walking program on musculoskeletal, endocrino-metabolic and cardiorespiratory health.
ClinicalTrials.gov, NCT03989752

Sites

  • Institut universitaire sur la réadaptation en déficience physique de Montréal (IURDPM)Montreal, Quebec, Canada